Medical News

RSS

Roundup: Mass. BCBS chief on health costs; Georgia insurance exchange, Arizona waiver request

Arizona Gov. Jan Brewer has signed emergency legislation authorizing her to request a two-year waiver from the CMS to reduce Medicaid rolls by 280,000 people. Brewer said in a statement she intends to request the waiver as early as Monday. She added that she plans to meet with HHS Secretary Kathleen Sebelius in the coming weeks to discuss "the dire need for a Medicaid waiver for Arizona".

24 Jan 2011

ArQule's ARQ 197 Phase 1 clinical trial results in colorectal cancer presented at ASCO 2011

ArQule, Inc. today announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal cancer (CRC) treated with ARQ 197, a selective small molecule inhibitor of the c-MET receptor tyrosine kinase, in combination with irinotecan and cetuximab. ARQ 197 is under development by Daiichi Sankyo Co., Ltd. and ArQule.

24 Jan 2011

In new Congress, Roe v. Wade anniversary draws out critics and defenders

As thousands of antiabortion activists streamed into the nation's capital to protest Saturday's 38th anniversary of Roe vs. Wade, the politics of abortion are heating up again on Capitol Hill. The election of the new Republican majority in the House of Representatives swept in scores of social conservatives, re-energizing the antiabortion movement in Congress.

24 Jan 2011

St. Jude Medical's Athena programmer DBS system receives Australian TGA approval

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Australian Therapeutic Goods Administration (TGA) of its Athena™ programmer, a deep brain stimulation (DBS) therapy management system.

24 Jan 2011

Threshold reports positive results from TH-302 Phase 1/2 clinical trial in pancreatic cancer

Threshold Pharmaceuticals, Inc. today announced updated Phase 1/2 clinical trial results related to the Company's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the ASCO Gastro Intestinal Cancers Symposium that took place in San Francisco from January 20-22, 2011.

24 Jan 2011

American Scientific Resources now quoted on OTCQB market

American Scientific Resources, Inc. wishes to announces that it is now quoted on the OTCQB market.

24 Jan 2011

CenterWatch quadruples size of Clinical Trials Listing Service

CenterWatch—a leading publisher of clinical trials information—announced that it has more than quadrupled the size of its Clinical Trials Listing Service™ (CTLS). The service now lists more than 80,000 active clinical trials across a wide range of disease conditions, making it the largest online and dynamic database of global clinical trials involving new drugs and devices regulated by the Food and Drug Administration and the Department of Health and Human Services.

24 Jan 2011

Hitachi Medical Systems America achieves top ranking among MRI vendors

In the 2010 Q4 User Satisfaction Survey, MD Buyline users have named Hitachi Medical Systems America (HMSA) the top rated MRI vendor. HMSA swept the top rankings in all six categories and earned a composite score 9.6 out of 10.

24 Jan 2011

Alexza's AZ-004 Phase 3 study in agitated patients with schizophrenia published in British Journal of Psychiatry

Alexza Pharmaceuticals, Inc. announced today that the British Journal of Psychiatry, a publication of the Royal College of Psychiatrists, has published the results of the pivotal Phase 3 study evaluating AZ-004 (inhaled or Staccato® loxapine) for the rapid treatment of agitation in patients with schizophrenia, in its January 2011 edition (198:51-58).

24 Jan 2011

Medisafe 1 Technologies' 2012 revenues to exceed $10M

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company expects revenues in 2012 to exceed $10M .

24 Jan 2011

Senesco files SNS01-T IND for treatment of multiple myeloma

Senesco Technologies, Inc. today announced that the Company has filed an Investigational New Drug application with the U.S. Food and Drug Administration for Senesco's lead drug candidate SNS01-T for treatment of multiple myeloma.

24 Jan 2011

Boston Scientific completes enrollment in comparison trial of SYNERGY Stent to PROMUS Element Stent

Boston Scientific Corporation today announced the completion of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Company's fourth-generation SYNERGY™ Coronary Stent. The randomized, single-blind, non-inferiority trial will compare the SYNERGY Stent to the PROMUS Element™ Everolimus-Eluting Coronary Stent in patients with a single de novo native coronary artery lesion.

24 Jan 2011

FDA accepts Optimer's fidaxomicin NDA for filing

Optimer Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for fidaxomicin for the treatment of Clostridium difficile infection (CDI) and for reducing the risk of recurrence when used for treatment of initial CDI.

24 Jan 2011

Women pregnant after egg donation are high-risk patients

Women who have become pregnant after egg donation should be categorized as high-risk patients. Why that is the case, and which consequences egg donation may have for women is the subject of a review article by Ulrich Pecks and co-authors from the University Hospital Aachen in the current issue of Deutsches Ärzteblatt International.

24 Jan 2011

Blue Cross and Blue Shield of Florida reduces IT costs with BMC software

With the help of BMC Software, Blue Cross and Blue Shield of Florida (BCBSF) is reducing costs while preparing for the new demands healthcare reform will bring to IT.

24 Jan 2011

Methodist DeBakey Heart & Vascular Center chosen for critical percutaneous heart valve study

The Methodist DeBakey Heart & Vascular Center was chosen today as a site for a critical percutaneous heart valve study. As part of the research study, Methodist physicians will replace diseased cardiac valves through a single, tiny puncture hole in the research subject's groin.

24 Jan 2011

NHLBI, HeartWare award $13.3M to study benefits of heart devices for heart failure

The University of Michigan Cardiovascular Center and the University of Pittsburgh have been awarded $13.3 million to explore the potential benefits of heart devices for the large and growing group of Americans with heart failure.

24 Jan 2011

Agenus enters research agreement with Memorial Sloan-Kettering Cancer Center

Agenus Inc. today announced it has entered into a research agreement with Memorial Sloan-Kettering Cancer Center (MSKCC) using Agenus' proprietary cancer vaccine technology.

24 Jan 2011

Spectrum submits Post Approval Supplement for removal of bioscan requirement for Indium-111 ZEVALIN

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Thursday, January 20, 2011, it submitted a Post Approval Supplement containing data supporting the removal of the Indium-111 ZEVALIN® pre-treatment imaging evaluation, more commonly referred to as the "bioscan" requirement.

24 Jan 2011

Rogue gene blocked by right drugs could stop cancer

Scientists at the University of East Anglia (UEA) have discovered a rogue gene which - if blocked by the right drugs - could stop cancer in its tracks.

24 Jan 2011

Medical News

Roundup: Mass. BCBS chief on health costs; Georgia insurance exchange, Arizona waiver request

ArQule's ARQ 197 Phase 1 clinical trial results in colorectal cancer presented at ASCO 2011

In new Congress, Roe v. Wade anniversary draws out critics and defenders

St. Jude Medical's Athena programmer DBS system receives Australian TGA approval

Threshold reports positive results from TH-302 Phase 1/2 clinical trial in pancreatic cancer

American Scientific Resources now quoted on OTCQB market

CenterWatch quadruples size of Clinical Trials Listing Service

Hitachi Medical Systems America achieves top ranking among MRI vendors

Alexza's AZ-004 Phase 3 study in agitated patients with schizophrenia published in British Journal of Psychiatry

Medisafe 1 Technologies' 2012 revenues to exceed $10M

Senesco files SNS01-T IND for treatment of multiple myeloma

Boston Scientific completes enrollment in comparison trial of SYNERGY Stent to PROMUS Element Stent

FDA accepts Optimer's fidaxomicin NDA for filing

Women pregnant after egg donation are high-risk patients

Blue Cross and Blue Shield of Florida reduces IT costs with BMC software

Methodist DeBakey Heart & Vascular Center chosen for critical percutaneous heart valve study

NHLBI, HeartWare award $13.3M to study benefits of heart devices for heart failure

Agenus enters research agreement with Memorial Sloan-Kettering Cancer Center

Spectrum submits Post Approval Supplement for removal of bioscan requirement for Indium-111 ZEVALIN

Rogue gene blocked by right drugs could stop cancer

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News